Please login to your online account to display your discounted pricing

Sino Biological™ PDCD1 Recombinant Human Protein, hIgG1-Fc.His Tag DFS Item

This recombinant protein was expressed from a DNA sequence encoding the extracellular domain (Met 1-Gln 167) of human PDCD1 (NP_005009.2) fused to the polyhistidine-tagged Fc region of human IgG1 at the C-terminus

$93.45 - $1,287.30

Specifications

Purity ≥90% by SDS-PAGE
Endotoxin Concentration <1 EU/μg
Format Lyophilized
Gene Alias PDCD1, PD1, CD279, SLEB2, hPD-1, hPD-l
View More Specs

 Disclaimers

For Research Use Only. Not for use in diagnostic procedures.

Products
Catalog Number Mfr. No. Quantity Price Quantity    

10377H03H25

DFS Item
 
life technologies
LS10377H03H25
5 x 5μg Each for $210.00

10377H03H5

DFS Item
 
life technologies
LS10377H03H5
5μg Each for $93.45

10377H03H50

DFS Item
 
life technologies
LS10377H03H50
50μg Each for $376.95

10377H03HL

DFS Item
 
life technologies
LS10377H03H250
5 x 50μg Each for $1,287.30
Description & Specifications

Specifications

Purity ≥90% by SDS-PAGE
Endotoxin Concentration <1 EU/μg
Format Lyophilized
Gene Alias PDCD1, PD1, CD279, SLEB2, hPD-1, hPD-l

Programmed cell death 1 (PDCD1), recombinant human protein is supplied as a lyophilized powder. It is suitable for use in protein studies such as protein structure analysis and protein-protein interactions. In general, recombinant proteins can also be used as an immunogen, as a protein standard, or in cell biology research applications.

  • Activity: Measured by its binding ability in a functional ELISA; immobilized recombinant human PDCD1LG2 at 1μg/mL (100μL/well) can bind human PDCD1-Fc chimera with a linear range of 7.8-1000ng/mL
  • Formulation: Lyophilized in 140mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4, pH 7.4, 5% Mannitol, 5% Trehalose, 0.02% Tween 80
  • Reconstitution: Dissolve the protein in sterile double distilled water to a concentration of 0.2mg/mL or lower; aliquot and use as soon as possible

This protein is manufactured by Sino Biological Inc.